Suven Life Sciences Limited — Board Meeting, 16-07-2025: Outcome of Board Meeting

Suven Life Sciences' Board has approved the conversion of 91.86 lakh warrants into new equity shares. These shares, issued at Rs 134 each on a preferential basis, have injected approximately Rs 123.10 crore into the company. Major investors include Quant Mutual Fund, Abakkus Diversified Alpha Fund, and Cobra India (Mauritius). This strategic move significantly increases Suven's paid-up capital and strengthens its financial standing.